Online Clinical Case Study (October 2003)

Clinical Cardiology Series
臨床心臟科個案研究

The content of the Clinical Cardiology Series is provided by:
Dr. Wong Shou Pang, Alexander
F.R.C.P., F.H.K.A.M.(Med.), F.H.K.C.P., Specialist in Cardiology
Dr. Li Siu Lung, Steven
M.B.,B.S.(H.K.), M.R.C.P.(U.K.), F.H.K.A.M., F.H.K.C.P., F.R.C.P.(Glasg.), Specialist in Cardiology
臨床心臟科個案研究之內容誠蒙王壽鵬醫生李少隆醫生提供。

A 45 year old gentleman comes to your office for advice on the management of his coronary heart disease. He is scheduled for a coronary angioplasty later for his stenosed coronary arteries. He would like to know more about the use of drug-eluting coronary stents during coronary angioplasty.

Answers

1.

What are drug-eluting stents (DES)?

DES are metal stents with drugs coated on their surface. The drug molecules can then be delivered locally to the treated segment of the coronary arteries to exert their effect.

 

Back to top

 

2.

What are the commonly available drug-eluting stents?

The two commonly available stents are Sirolimus-eluting stents (Cypher) and Paclitaxel-eluting stents (Taxus).

 

Back to top

 

3.

What are the mechanisms of DES in reducing restenosis?

 

Restenosis after balloon angioplasty and stent implantation is due to local neointimal hyperplasia. The drugs on DES inhibit smooth muscle cell proliferation and thereby prevent neointimal hyperplasia.

 

Back to top

 

4.

What is the restenosis rate of drug-eluting stents?

 

Depending on the size of the vessels and the characteristics of the lesions and the patients, the restenosis rate of traditional bare stents may be up to 20-40%. The restenosis rate of DES is reduced down to 5-8%.

 

Back to top

 

5.

How safe are drug-eluting stents?

 

There is no excessive major adverse cardiac event when compared with bare stents.

 

Back to top

 


Dermatology Series 皮膚科病例研究

A 35 year old lady presented with recurrent itchy wheals and red lines for one year. There was no obvious precipitating factor for the skin rash. She enjoyed good general health and there was no family history for skin diseases. A test was done on the back (figure).

The content of the Dermatology Series is provided by:
Dr. Tang Yuk Ming, William and Dr. Chan Loi Yuen
Specialist in Dermatology & Venereology

皮膚科病例研究之內容誠蒙鄧旭明醫生陳來源醫生提供。

Answers

1. What is the clinical diagnosis?

Chronic idiopathic urticaria (CIU) and symptomatic dermographism. CIU refers to frequent occurrence of urticaria lasting longer than six weeks without any obvious causes as excluded by careful history and clinical examination and sometimes a battery of laboratory tests. Symptomatic dermographism is a form of physical urticaria induced by stroke or scratching.

 

Back to top

 

2.

What feature is shown in the photo?

The patient shows a positive dermographic test. Direct pressure, as induced by drawing a line on the skin results in itchy wheal.

 

Back to top

 

3. How persistent is an individual lesion?

Individual urticarial lesion resolves from within minutes to hours and seldom exceed 24 hours. However, while lesions resolve, new lesions may appear on other sites.

 

Back to top

 

4. What investigations are usually carried out for the condition?

The laboratory tests commonly employed include complete blood count with differential, thyroid function test, antithyroid antibodies, antinuclear antibody, and stool for ova and cyst. However, none of these tests are diagnostically important for the condition. A positive test may not imply a direct causal relationship with the urticaria. In some patients, intradermal injection of their sera reproduces urticarial lesions (positive autologous serum test) and recent evidence has shown that a subset of CIU is an autoimmune disorder.

 

Back to top

 

5.

What is the treatment?

Factors that would exacerbate urticaria in that individual patient should be avoided. Alcohol, nonsteroidal anti-inflammatory drugs and aspirin which cause mast cell degranulation should only be taken with caution and medical advice. Heat, pressure and scratching could also increase itching in CIU and symptomatic dermographism, and hence these factors should also be avoided. Oral antihistamines are the first line treatment, and selective H1 blockers have the advantage of being non-sedative. A short course of systemic steroid is effective for acute exacerbation but should not be used on a long-term basis. Rarely, CIU may be associated with angioedema which requires urgent medical management.

 

Back to top

 

Back to Online Clinical Case Study